A DNA methylation-based liquid biopsy for triple-negative breast cancer
Here, we present a next-generation sequencing (NGS) methylation-based blood test called
methylation DETEction of Circulating Tumour DNA (mDETECT) designed for the optimal …
methylation DETEction of Circulating Tumour DNA (mDETECT) designed for the optimal …
Treatments During Pregnancy Targeting ERBB2 and Outcomes of Pregnant Individuals and Newborns
…, S Barraud, B Asselain, E Dumas, C Sebbag… - JAMA Network …, 2023 - jamanetwork.com
Importance Targeted therapies directed against ERBB2 are the cornerstone of medical
treatment for ERBB2-positive breast cancers but are contraindicated during pregnancy. …
treatment for ERBB2-positive breast cancers but are contraindicated during pregnancy. …
Pregnancy, fertility concerns and fertility preservation procedures in a national study of French breast cancer survivors
M Mangiardi-Veltin, C Sebbag… - Reproductive …, 2022 - Elsevier
Research question What are the real-life oncofertility practices in young women diagnosed
with breast cancer? Design The FEERIC (FErtility, prEgnancy, contRaceptIon after breast …
with breast cancer? Design The FEERIC (FErtility, prEgnancy, contRaceptIon after breast …
Time to pregnancy, obstetrical and neonatal outcomes after breast cancer: a study from the Maternity Network for Young Breast Cancer Patients
J Labrosse, A Lecourt, A Hours, C Sebbag, A Toussaint… - Cancers, 2021 - mdpi.com
Simple Summary Little is known on the time necessary to obtain a pregnancy after breast
cancer and on the subsequent obstetrical and neonatal outcomes. We analyzed a cohort of …
cancer and on the subsequent obstetrical and neonatal outcomes. We analyzed a cohort of …
Text mining in electronic medical records enables quick and efficient identification of pregnancy cases occurring after breast cancer
J Labrosse, T Lam, C Sebbag, M Benque… - JCO clinical cancer …, 2019 - ascopubs.org
PURPOSE To apply text mining (TM) technology on electronic medical records (EMRs) of
patients with breast cancer (BC) to retrieve the occurrence of a pregnancy after BC diagnosis …
patients with breast cancer (BC) to retrieve the occurrence of a pregnancy after BC diagnosis …
Clinical Utility of Pre-Therapeutic [18F] FDG PET/CT Imaging for Predicting Outcomes in Breast Cancer
…, L Champion, A De Moura, C Sebbag… - Journal of Clinical …, 2023 - mdpi.com
Background: [18F]FDG PET/CT is used for staging and could also provide information associated
with clinical outcomes. The objective of this study was to determine the clinical utility of …
with clinical outcomes. The objective of this study was to determine the clinical utility of …
Pregnancy, fertility concerns, and fertility preservation procedures in French breast cancer survivors in the FEERIC national study (on behalf of the Seintinelles …
M Mangiardi-Veltin, C Sebbag, C Rousset-Jablonski… - medRxiv, 2021 - medrxiv.org
Objective To study fertility concerns and oncofertility practices at time of breast cancer (BC)
diagnosis. Design The FEERIC study (Fertility, Pregnancy, Contraception after BC in France) …
diagnosis. Design The FEERIC study (Fertility, Pregnancy, Contraception after BC in France) …
A DNA methylation-based liquid biopsy for triple-negative breast cancer
Here, we present a next-generation sequencing (NGS) methylation-based blood test called
methylation DETEction of Circulating Tumour DNA (mDETECT) designed for the optimal …
methylation DETEction of Circulating Tumour DNA (mDETECT) designed for the optimal …
Contraception in breast cancer survivors from the FEERIC case-control study (performed on behalf of the Seintinelles research network)
C Sebbag, C Rousset-Jablonski, F Coussy… - The Breast, 2023 - Elsevier
Objective To compare the prevalence of contraception in breast cancer (BC) patients at risk
of unintentional pregnancy (ie not currently pregnant or trying to get pregnant) and matched …
of unintentional pregnancy (ie not currently pregnant or trying to get pregnant) and matched …
Abstract PS13-10: Impact of BRCA mutation status on immune infiltration, chemosensitivity, and prognosis of breast cancer patients treated with neoadjuvant …
Context: The majority of BRCA mutation carriers diagnosed with breast cancer (BC) are
treated with chemotherapy. The effectiveness of standard neoadjuvant chemotherapy (NAC) in …
treated with chemotherapy. The effectiveness of standard neoadjuvant chemotherapy (NAC) in …
